101 Followers on Owler

InterMune

engages in the research, development and commercialization of therapies in pulmonology and orphan fibrotic diseases... Read more
OverviewCompetitorsFundingNews & Insights

InterMune

engages in the research, development and commercialization of therapies in pulmonology and orphan fibrotic diseases... Read more
InterMune President & CEO: Daniel G. Welch

President & CEO

Daniel G. Welch

CEO Approval Rating

65/100

01/1998

PrivateAcquired by Legacy Pharma Inc.

Pharmaceuticals & Biotechnology
Add Sector
28342836 NAICS listing

Est. Annual Revenue
$100-500M
Agree?
Est. Employees
250-500
Agree?
Funding
$125M

News

Acquisition
Feb 07, 2025
Benzinga
InterMune Was acquired by Legacy Pharma Inc. for undisclosed amounted

InterMune Competitors

1Merck
2AstraZeneca
3Bristol-Myers Squibb
4Sangamo
5Ultragenyx
6Array BioPharma
7Halozyme
8Johnson & Johnson
9Sofinnova Ventures
10Roche
Unlock 21 + competitors

Trending Companies